Interestingly, PI3K inhibitors alone had little effect on STAT3 phosphorylation in T-ALL cells, suggesting that JAK/STAT3 activation might drive a partial resistance to PI3K inhibitors. Here, PIK3CD is linked to acute lymphoblastic leukemia.